Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
2-(((3aR,4S,6R,6aS)-6-Amino-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol oxalate is an important drug intermediate that plays a crucial role in the synthesis of diverse bioactive compounds. It facilitates the development of pharmaceuticals by serving as a key building block in medicinal chemistry. This compound is instrumental in research applications focused on tailored drug design and optimization. -
Drug Intermediate
1-(2-(4-(Chloromethyl)phenoxy)ethyl)azepane hydrochloride is a valuable drug intermediate utilized in the synthesis of diverse bioactive compounds. This reagent serves as a crucial building block, contributing to the development of pharmaceuticals with potential therapeutic applications. Researchers can leverage its chemical properties to facilitate the formation of complex molecular structures in drug discovery and development processes. -
Drug Intermediate
1-(3-Ethyl-4-(hydroxymethyl)phenyl)ethan-1-one functions as a versatile drug intermediate in the synthesis of various active pharmaceutical compounds. Its structural characteristics make it suitable for applications in medicinal chemistry and drug development. Researchers can utilize this compound to facilitate the formation of complex molecules with potential therapeutic properties. -
Drug Intermediate
(1R,2S)-1-tert-Butoxycarbonylamino-2-vinylcyclopropanecarboxylic acid serves as a crucial drug intermediate in the synthesis of various bioactive compounds. Its unique structural features enable it to participate in complex chemical reactions, facilitating the development of pharmaceuticals. This compound is ideal for researchers engaged in the synthesis of novel therapeutic agents. -
Drug Impurity
Rivaroxaban impurity 50, also known as thiophene-2-carboxylate, is a known impurity associated with Rivaroxaban. This compound is pertinent for quality control and analytical research in pharmaceutical development, particularly in evaluating the purity of Rivaroxaban. Its presence and quantification are critical for ensuring the safety and efficacy of finished drug products. -
Drug Intermediate
(2S,4S)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid serves as a crucial drug intermediate in the synthesis of various bioactive compounds. This intermediate is characterized by its structural features, which facilitate the development of pharmacologically relevant molecules. Its applications extend to medicinal chemistry and the design of novel therapeutics, making it an essential component in pharmaceutical research and development. -
Drug Intermediate
tert-Butyl 4-(2-carbamoylbenzofuran-5-yl)piperazine-1-carboxylate serves as a versatile drug intermediate in the synthesis of diverse bioactive compounds. This reagent is pivotal for developing pharmaceuticals with potential therapeutic applications, particularly in the fields of neuroscience and oncology. Its structural characteristics facilitate the construction of complex molecular architectures, thereby aiding in drug discovery and medicinal chemistry research. -
Drug Intermediate
Dimethyl (3,3-difluoro-2-oxoheptyl)phosphonate is a key drug intermediate utilized in the synthesis of various active pharmaceutical compounds. This reagent plays an essential role in the production of molecules with biological significance, particularly those involved in medicinal chemistry. Its structural characteristics enable the development of targeted therapies and contributions to pharmacological research. -
Drug Intermediate
5-Methyl-2-(pyrimidin-2-yl)benzoic acid serves as a valuable drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its structure facilitates the development of compounds with potential therapeutic applications, particularly in the fields of medicinal chemistry and drug discovery. Researchers utilize this compound to explore a variety of biological activities, contributing to advancements in pharmacology and the development of novel treatments. -
Drug Intermediate
Methyl 1-(2-chloroacetyl)-2-oxoindoline-6-carboxylate is a key drug intermediate utilized in the synthesis of diverse active pharmaceutical compounds. It plays a crucial role in chemical research involving indoline derivatives, facilitating the development of potential therapeutic agents. Its properties make it valuable for studies related to drug design and molecular synthesis. -
Drug Intermediate
1-Brom-4,5-dimethyl-2-nitro-benzene serves as an important drug intermediate in the synthesis of various bioactive compounds. Its structure facilitates the formation of substituted aromatic products, making it a valuable reagent in medicinal chemistry. This compound is utilized in the development of pharmaceuticals and chemical research, contributing to the advancement of drug design and discovery. -
Drug Intermediate
(R)-tert-Butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate serves as an essential drug intermediate for the synthesis of diverse biologically active compounds. Its complex structure allows for the development of innovative therapeutic agents, making it valuable in pharmaceutical research. The compound's unique chemical properties facilitate research into new drug formulations and applications. -
Drug Intermediate
4-((2-Aminoethyl)(5-chlorobenzo[d]oxazol-2-yl)amino)butan-2-one dimethanesulfonate serves as a drug intermediate in chemical synthesis. This compound is instrumental in the production of various active pharmaceutical ingredients, facilitating research and development in drug formulation. Its structure enables the creation of compounds that may exhibit significant biological activity, underscoring its importance in medicinal chemistry. -
Drug Intermediate
6,7-Dimethoxy-2-tetralone is a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical compounds. This molecule plays a critical role in organic synthesis, facilitating the development of novel therapeutic agents. Its structural framework is essential for researchers exploring pharmacological activities and medicinal chemistry applications. -
Drug Intermediate
(S)-Pregabalin methyl ester hydrochloride serves as a drug intermediate with applications in pharmaceutical synthesis. This compound retains the structural properties of Pregabalin, facilitating research into its potential therapeutic effects. It is often utilized in the development of treatments for neuropathic pain and seizure disorders, contributing to advancements in medicinal chemistry and drug formulation. -
Drug Intermediate
4-Bromo-6-fluoro-1H-indazole serves as a critical intermediate in drug synthesis, primarily employed in the development of inhibitors targeting hematopoietic progenitor kinase 1 (HPK1). This compound facilitates the exploration of HPK1 modulation in various biological pathways and shows potential in therapeutic applications related to hematopoietic cell regulation and related diseases. -
Drug Intermediate
(S)-1-Benzylpyrrolidin-3-ol serves as a valuable drug intermediate in synthetic chemistry. It is utilized primarily for the production of impurities associated with the anti-hypertensive agent Barnidipine hydrochloride. This compound plays a critical role in ensuring the quality and efficacy of pharmaceutical formulations through comprehensive analysis and quality control. -
Drug Intermediate
5-Bromopentanoic acid is a versatile drug intermediate that serves as a building block in the synthesis of compounds targeting aminoglycoside-resistant bacteria. Its reactivity enables the development of novel inhibitors, facilitating important research focused on combating antibiotic resistance. This compound is useful in pharmaceutical research and development aimed at addressing emerging microbial threats. -
Drug Intermediate
N-tert-Boc-cis-4-fluoro-L-proline is a key drug intermediate utilized in the synthesis of 4-fluoropyrrolidine-2-carbonitrile, a DPP-4 inhibitor. This compound plays a significant role in research applications related to type 2 diabetes, facilitating investigations into its therapeutic mechanisms and potential treatments. Its structural properties allow for the exploration of metabolic pathways and the development of novel pharmacological agents. -
Drug Intermediate
6-Bromonicotinic acid is a brominated derivative of niacin that serves as a valuable drug intermediate. It is primarily utilized in the synthesis of Anabaseine derivatives, which are important in the development of pharmacological agents. This compound facilitates research in medicinal chemistry and aids in the exploration of therapeutic applications within the field. -
Drug Intermediate
5-Bromo-1H-pyrazolo[3,4-b]pyridine is a key intermediate in the synthesis of sulfonamide derivatives. This compound serves as an important building block in the development of various pharmacological agents. Its distinctive structure enables the exploration of new therapeutic applications, making it valuable for medicinal chemistry research. -
Drug Intermediate
1-Acetyl-6-amino-3,3-dimethylindoline is a key drug intermediate primarily utilized in the synthesis of various active pharmaceutical compounds. Its unique structure features an acetyl group and an amino group bonded to a dimethylindoline core, facilitating its role in medicinal chemistry. This compound is essential for the development of novel therapeutics and can be employed in diverse research applications focused on drug discovery and synthesis. -
Drug Impurity
Ledipasvir impurity 53 is a known impurity of the antiviral compound Ledipasvir, which acts primarily as an NS5A inhibitor. This chemical research reagent is relevant for studies focusing on the characterization and analysis of drug purity in pharmaceutical development and quality control. Its presence and quantification can provide insights into the synthesis and stability of ledipasvir-containing formulations, facilitating improved quality assurance practices. -
Drug Intermediate
1-Isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid serves as a versatile drug intermediate in the synthesis of various biologically active compounds. This compound is essential for the development of novel pharmaceuticals, particularly those targeting quinoline derivatives. Its role in synthetic pathways makes it a valuable reagent for chemical research and development applications. -
Drug Intermediate
7-Fluoro-2-tetralone is a versatile drug intermediate primarily utilized in the synthesis of various bioactive compounds. This compound plays a crucial role in the development of pharmaceuticals, facilitating the creation of novel therapeutic agents. Its chemical structure enables precise modifications, making it valuable in medicinal chemistry and drug discovery research. -
Drug Intermediate
5,5'-Oxybis(isobenzofuran-1,3-dione) serves as a valuable drug intermediate in the synthesis of diverse bioactive compounds. It facilitates the formation of complex molecular structures, playing a pivotal role in the development of therapeutics. This compound is widely utilized in chemical research to explore new medicinal properties and enhance drug efficacy. -
Drug Intermediate
3-Benzyl-6-bromo-1H-quinolin-2-one serves as a crucial drug intermediate in the synthesis of diverse pharmacologically active compounds. This molecule is instrumental in facilitating the development of novel therapeutic agents. Its structural features allow for further modifications, making it valuable in medicinal chemistry and drug discovery research. -
Drug Impurity
3-Ethoxy-4-hydroxybenzonitrile is identified as a drug impurity with potential significance in pharmaceutical development. This compound may influence the stability, efficacy, and safety profiles of drug formulations. Its presence should be monitored in analytical assays to ensure quality control and regulatory compliance in chemical research and drug manufacturing applications. -
Drug Intermediate
1-tert-Butyl 3-methyl 3-hydroxyazetidine-1,3-dicarboxylate serves as a crucial drug intermediate utilized in the synthesis of a variety of bioactive compounds. Its structural features facilitate the formation of complex molecules, making it valuable in pharmaceutical research and development. This compound plays a significant role in the production of active pharmaceutical ingredients (APIs) and contributes to the advancement of therapeutic agents. -
Drug Intermediate
4-Amino-3-nitropyridin-2-ol serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound is integral to the development of various biologically active molecules, facilitating research in medicinal chemistry and drug discovery. Its structural attributes support the exploration of new therapeutic agents and their mechanisms of action. -
Drug Impurity
Mesalazine impurity 2 is a known impurity associated with the anti-inflammatory drug Mesalazine. This compound is utilized primarily in analytical chemistry for quality control and characterization of Mesalazine formulations. Its presence can impact the efficacy and safety of pharmaceutical products, making it important for drug development and regulatory compliance studies. -
Drug Intermediate
6,7,8,9,10,11-Hexahydrocyclooct[b]Indole is a versatile drug intermediate utilized in the synthesis of diverse bioactive compounds. This compound plays a critical role in the development of pharmaceuticals and can facilitate the creation of innovative therapeutic agents. Its unique structure offers potential applications in medicinal chemistry research and drug discovery efforts. -
Drug Intermediate
4-((2-Cyanopropan-2-yl)amino)-2-fluoro-N-methylbenzamide is a key drug intermediate utilized in the synthesis of various pharmaceutical compounds. This molecule serves as a building block for the development of biologically active agents, specifically in studies aimed at enhancing therapeutic efficacy and potency. Its unique structure can facilitate the exploration of novel drug formulations and contribute to medicinal chemistry research. -
Drug Impurity
Cholic acid impurity 1 is a chemical impurity associated with cholic acid, a primary bile acid involved in the digestion and absorption of fats. This compound is crucial for quality control and characterization in pharmaceutical research, particularly in the context of drug formulation and assessment of purity. Cholic acid impurity 1 supports investigations into the safety and efficacy of compounds that include cholic acid within their formulations. -
Drug Intermediate
4-(2,4-Difluorophenoxy)benzoic acid serves as a key drug intermediate in the synthesis of various biologically active compounds. Its structural features facilitate the development of novel pharmaceuticals, making it valuable in medicinal chemistry research. This compound is crucial in studies aiming to optimize drug delivery and efficacy. -
Drug Intermediate
4-(2-(4-Morpholinophenylamino)pyrimidin-4-yl)benzoic acid serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. This compound exhibits potential for use in the development of pharmaceuticals targeting various biological pathways. Its structural features facilitate modifications that can enhance the efficacy and specificity of resultant drug candidates, making it a valuable tool for chemical biology research. -
Drug Intermediate
6-Benzothiazolemethanamine dihydrochloride serves as a drug intermediate in the synthesis of diverse bioactive compounds. It plays a crucial role in the development of pharmaceuticals and facilitates the exploration of novel therapeutic agents. This reagent is valuable for researchers focused on medicinal chemistry and drug development applications. -
Drug Intermediate
(R)-Tetrahydrofuran-2-yl-methylamine is a synthetic intermediate that serves a critical role in pharmaceutical synthesis. Its unique structural properties facilitate the development of biologically active compounds. This reagent is valuable in research applications focusing on the synthesis of various therapeutic agents. -
Drug Intermediate
5-Benzyl-5-azaspiro[2.4]heptane-4,7-dione serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound facilitates the development of novel therapeutic agents by providing a modular scaffold for further chemical modifications. Its unique structure is advantageous in medicinal chemistry, particularly in the exploration of biological activities pertinent to drug discovery. -
Drug Impurity
Methyl phenyl sulfone is a sulfone compound often identified as a drug impurity in pharmaceutical formulations. It can affect drug stability and bioavailability, making it significant in analytical chemistry and quality control. Researchers utilize this reagent to assess purity in drug synthesis and to evaluate the potential impact of impurities on pharmacological profiles. -
Drug Intermediate
1-(3-Chloropropyl)-3-(trifluoromethyl)benzene serves as a crucial drug intermediate in the synthesis of a variety of active pharmaceutical ingredients. Its unique structural features and reactivity make it valuable for medicinal chemistry applications, particularly in the development of compounds targeting specific biological pathways. This reagent is essential for researchers focusing on the synthesis and functional evaluation of novel therapeutic agents. -
Drug Impurity
Tofacitinib impurity 3 is a known impurity of the JAK1/3 inhibitor Tofacitinib. It is primarily utilized for assessing the purity and quality of Tofacitinib in pharmaceutical formulations. This impurity serves as a valuable reference standard in the development and analysis of therapeutic agents targeting immune-mediated disorders. -
Drug Intermediate
1-(6-Aminonaphthalen-2-yl)ethan-1-one serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. Its structural properties facilitate the development of compounds with potential therapeutic applications. This reagent is particularly valuable in medicinal chemistry for the design and synthesis of novel bioactive molecules. -
Drug Intermediate
(R)-Ethyl 5-(2,2-dimethyltetrahydro-2H-pyran-4-yl)-1H-indole-2-carboxylate serves as a versatile drug intermediate in the synthesis of diverse bioactive compounds. Its unique structural characteristics facilitate the development of indole derivatives and other pharmacologically relevant agents. This compound is valuable for researchers engaged in medicinal chemistry and drug discovery efforts. -
Drug Intermediate
(5-Amino-2-butylbenzofuran-3-yl)(4-(3-(dibutylamino)propoxy)phenyl)methanone serves as a critical drug intermediate in the synthesis of diverse bioactive compounds, particularly in the development of antiarrhythmic agents. This compound plays a significant role in facilitating the preparation and optimization of pharmacologically relevant molecules for cardiac research. Its functionalities enable researchers to explore novel therapeutic strategies in the treatment of atrial fibrillation and other cardiovascular conditions. -
Drug Intermediate
3-Fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol acts as a versatile drug intermediate in organic synthesis. This compound facilitates the development of various biologically active molecules, making it an important building block in pharmaceutical research. Its unique structural features contribute to its utility in creating complex compounds for therapeutic applications. -
Drug Impurity
Metformin impurity 1 is a known impurity associated with the antidiabetic agent Metformin. This compound is important for quality control and regulatory compliance in pharmaceutical research, particularly in the analysis of drug formulations. Its presence and characterization are critical for ensuring the purity and efficacy of Metformin-containing products. -
Drug Intermediate
2-(Naphthalen-2-yl)acetonitrile is a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. Its structural properties make it conducive for research applications focused on the development of therapeutic compounds. Researchers leverage this reagent for its role in facilitating complex chemical reactions integral to drug discovery and development. -
Drug Intermediate
(2S,4S)-1-((S)-2-Amino-3,3-Dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride is a specialized drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. It serves as a critical building block in medicinal chemistry, facilitating the development of compounds with potential therapeutic applications. This reagent is essential for researchers engaging in drug development and optimization processes. -
Drug Intermediate
3-Hydroxy-2-methylpyridine serves as a critical drug intermediate in the synthesis of pyrimidines. It exhibits potential as a corrosion inhibitor, making it valuable in various industrial applications. Its role in organic synthesis and material protection highlights its importance in pharmaceutical and chemical research.
